Association between glucagon-like peptide-1 receptor agonists and colorectal cancer survival: A population-based cohort study
In this real-world cohort of diabetic patients treated for colorectal cancer, GLP1-RA therapy was associated with a significant improvement in overall survival. These findings support the continued use of GLP1-RA agents in this population and may provide reassurance to clinicians and patients regarding the safety and potential benefit of these agents following a colorectal cancer diagnosis.
Authors
- Thierry Lecomte
- Nadia Sabbah (ORCID: https://orcid.org/0000-0002-7789-6728)
- Laurent Fauchier
- Grégoire Fauchier
- Pierre Henri Ducluzeau
- Arnaud Dosda
Institutions
- Université de Tours (FR)
- Inserm (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Physiologie de la Reproduction et des Comportements (FR)
Publication Details
- Journal
- Diabetes & Metabolism
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1016/j.diabet.2026.101734
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 30.73